Genetic Manipulation of Cultured Cells
Expert-defined terms from the Certified Specialist Programme in Cell Culture course at LearnUNI. Free to read, free to share, paired with a professional course.
Acoustic Microinjection #
Acoustic Microinjection
Explanation #
A technique that uses focused acoustic waves to create transient pores in the cell membrane, allowing DNA, RNA, or protein delivery. The method reduces mechanical stress compared to traditional needle‑based microinjection. Example: delivery of CRISPR‑Cas9 ribonucleoprotein complexes into stem cells using a 1 MHz transducer. Practical application: rapid generation of knockout cell lines without extensive cell handling. Challenges include optimizing acoustic pressure to avoid cell lysis and ensuring uniform delivery across heterogeneous cultures.
Allele‑Specific PCR #
Allele‑Specific PCR
Explanation #
A polymerase chain reaction designed to amplify only one allele of a polymorphic site, enabling detection of point mutations introduced by genome editing. Example: confirming the presence of a single‑base insertion created by CRISPR in the EGFR gene. Practical application: quick screening of clonal populations after transfection. Challenges involve primer design to prevent cross‑amplification and managing false‑positive signals caused by low‑level contamination.
Antisense Oligonucleotide #
Antisense Oligonucleotide
Explanation #
Short, synthetic strands of nucleic acid that bind complementary mRNA sequences, blocking translation or altering splicing patterns. Example: use of a 20‑mer phosphorothioate ASO to suppress mutant huntingtin expression in neuronal cultures. Practical application: therapeutic gene knock‑down without permanent genome alteration. Challenges include delivery efficiency, off‑target hybridization, and potential activation of innate immune pathways.
Barcoding (Cell Line) #
Barcoding (Cell Line)
Explanation #
Insertion of a unique DNA sequence into a safe‑harbor locus of each cell line, permitting identification of individual clones in pooled experiments. Example: integrating a 12‑base barcode into the AAVS1 site of HEK293 cells to monitor clonal expansion after drug treatment. Practical application: high‑throughput screening of genetic perturbations. Challenges involve maintaining barcode stability over many passages and avoiding recombination events that alter the tag.
Base Editing #
Base Editing
Explanation #
A genome‑editing approach that fuses a catalytically impaired Cas nuclease with a DNA deaminase, enabling precise conversion of C·G to T·A or A·T to G·C without double‑strand breaks. Example: correcting a pathogenic G>A mutation in the β‑globin gene of cultured erythroid progenitors. Practical application: generation of disease‑model cell lines with minimal indel formation. Challenges include off‑target deamination, limited editing windows, and delivery of the larger base‑editor construct.
Bioreactor‑Based Transfection #
Bioreactor‑Based Transfection
Explanation #
Utilization of stirred‑tank or wave bioreactors to perform large‑volume transfections, often employing polyethylene glycol (PEG) or lipid reagents. Example: transfecting 10 L of CHO‑S cells grown on microcarriers with a plasmid encoding a monoclonal antibody. Practical application: production‑scale generation of recombinant protein‑expressing cell banks. Challenges include ensuring uniform reagent distribution, shear stress management, and maintaining cell viability during agitation.
CRISPR‑Cas9 #
CRISPR‑Cas9
Explanation #
The most widely used genome‑editing system, employing a guide RNA to direct the Cas9 nuclease to a specific DNA locus, creating a double‑strand break that is repaired by non‑homologous end joining (NHEJ) or homology‑directed repair (HDR). Example: knocking out the TP53 gene in human fibroblasts by delivering Cas9‑sgRNA ribonucleoprotein complexes via electroporation. Practical application: rapid creation of loss‑of‑function models for functional genomics. Challenges involve off‑target cleavage, delivery toxicity, and low HDR efficiency in non‑dividing cells.
CRISPR‑Cas12a (Cpf1) #
CRISPR‑Cas12a (Cpf1)
Explanation #
An alternative class 2 nuclease that recognizes a T‑rich protospacer adjacent motif and creates staggered cuts, facilitating easier multiplexing due to its ability to process a single CRISPR array. Example: simultaneous targeting of three cytokine genes in primary T cells using a single crRNA transcript. Practical application: generation of multi‑gene knockout cell lines in a single transfection step. Challenges include variable cutting efficiency across targets and the need for precise crRNA design.
CRISPR Interference (CRISPRi) #
CRISPR Interference (CRISPRi)
Explanation #
Uses a catalytically dead Cas9 (dCas9) fused to a transcriptional repressor (e.g., KRAB) to block gene expression without altering the DNA sequence. Example: silencing the MYC oncogene in cultured breast cancer cells by delivering dCas9‑KRAB and a guide RNA targeting the promoter region. Practical application: reversible gene knock‑down for functional studies. Challenges include incomplete repression, potential epigenetic memory, and off‑target binding of dCas9.
CRISPR Activation (CRISPRa) #
CRISPR Activation (CRISPRa)
Explanation #
Similar to CRISPRi, but dCas9 is fused to transcriptional activators (e.g., VP64, p65, Rta) to up‑regulate target gene expression. Example: inducing endogenous insulin production in pancreatic β‑cell lines by targeting the INS promoter with dCas9‑VP64. Practical application: functional rescue of haploinsufficient phenotypes. Challenges include achieving sufficient activation levels, guide RNA positioning, and potential activation of neighboring genes.
Donor Vector (HDR Template) #
Donor Vector (HDR Template)
Explanation #
A DNA construct that provides a template for homology‑directed repair after a CRISPR‑induced break, containing the desired edit flanked by sequences homologous to the target locus. Example: a circular plasmid with 800 bp homology arms used to insert a FLAG tag at the C‑terminus of the GAPDH gene. Practical application: precise knock‑in of epitope tags, fluorescent reporters, or therapeutic mutations. Challenges include low HDR efficiency, vector size constraints, and potential random integration.
Electroporation #
Electroporation
Explanation #
A physical method that applies an electric field to transiently permeabilize the cell membrane, allowing nucleic acids, proteins, or ribonucleoprotein complexes to enter the cytoplasm. Example: delivering Cas9‑sgRNA ribonucleoproteins into primary mouse fibroblasts using a 2 ms, 1400 V pulse. Practical application: high‑efficiency genome editing in hard‑to‑transfect cell types. Challenges involve optimizing voltage and pulse duration to balance transfection efficiency with cell viability, and managing heat generation in large‑volume formats.
Emulsion PCR (ePCR) #
Emulsion PCR (ePCR)
Explanation #
Amplification of DNA within water‑in‑oil droplets, enabling clonal amplification of individual templates, often used to generate CRISPR guide‑RNA libraries. Example: creating a pooled sgRNA library targeting all kinases in a 5 µL emulsion before lentiviral packaging. Practical application: large‑scale loss‑of‑function screens in cultured cell populations. Challenges include droplet stability, uniformity of amplification, and downstream recovery of the amplified library.
Epigenome Editing #
Epigenome Editing
Explanation #
Fusion of dCas9 to epigenetic modifiers (e.g., DNMT3A, TET1, p300) to alter chromatin states at specific loci without changing the underlying DNA sequence. Example: recruiting dCas9‑p300 to the promoter of the SOX2 gene to increase its transcription in neural progenitor cells. Practical application: studying the role of epigenetic regulation in differentiation and disease. Challenges include achieving locus‑specific modification, reversibility of changes, and off‑target epigenetic effects.
Exon‑Skip Editing #
Exon‑Skip Editing
Explanation #
Targeted disruption of splice‑acceptor or donor sites to induce exon skipping, restoring the reading frame of genes with deleterious mutations. Example: CRISPR‑mediated disruption of exon 51 splice sites in the DMD gene of patient‑derived myoblasts to produce a functional dystrophin isoform. Practical application: generation of disease‑model cell lines for therapeutic testing. Challenges involve precise splice‑site editing, potential creation of cryptic splice sites, and variable expression of the skipped transcript.
Flp‑FRT Recombination #
Flp‑FRT Recombination
Explanation #
A bacterial recombination system that mediates exchange between Flp recombinase recognition target (FRT) sites, allowing insertion or removal of genetic elements. Example: excising a selectable marker flanked by FRT sites after successful integration of a gene of interest in a CHO cell line. Practical application: creation of clean, marker‑free cell lines for biopharmaceutical production. Challenges include incomplete recombination, potential cross‑talk with endogenous pseudo‑FRT sites, and the need for transient Flp expression.
Flow Cytometry‑Based Sorting (FACS) #
Flow Cytometry‑Based Sorting (FACS)
Explanation #
A technique that separates cells based on fluorescent markers, enabling isolation of successfully edited populations after transfection. Example: sorting GFP‑positive HEK293 cells 48 h after delivery of a CRISPR plasmid encoding GFP as a reporter. Practical application: enrichment of edited clones prior to clonal expansion. Challenges include phototoxicity, sorter‑induced stress, and the requirement for a reliable fluorescent reporter linked to the editing event.
Gene Trap #
Gene Trap
Explanation #
A mutagenesis strategy where a vector containing a splice acceptor and a selectable marker integrates randomly, disrupting endogenous genes and reporting the insertion site. Example: using a neo‑bearing gene‑trap retrovirus to generate loss‑of‑function mutants in a mouse embryonic fibroblast library. Practical application: genome‑wide functional screens without prior knowledge of target genes. Challenges involve insertion bias, potential activation of neighboring genes, and difficulty in mapping insertion sites.
Homology‑Directed Repair (HDR) #
Homology‑Directed Repair (HDR)
Explanation #
A cellular DNA repair pathway that uses a homologous sequence as a template to accurately repair double‑strand breaks, enabling precise insertion of desired genetic changes. Example: insertion of a luciferase reporter into the endogenous ROSA26 locus of mouse embryonic stem cells using a single‑strand oligodeoxynucleotide donor. Practical application: generation of reporter cell lines and precise disease‑model alleles. Challenges include low efficiency in non‑dividing cells, competition with NHEJ, and the need for cell‑cycle synchronization.
Inducible Promoter System #
Inducible Promoter System
Explanation #
A regulatory element that initiates transcription only in the presence of an inducer molecule, allowing temporal control over transgene expression. Example: a Tet‑On system driving Cas9 expression in response to 1 µg/mL doxycycline in a stable HEK293 line. Practical application: reducing toxicity of constitutive nucleases and enabling staged editing. Challenges include leaky basal expression, inducer cytotoxicity, and potential epigenetic silencing over long‑term culture.
Lentiviral Transduction #
Lentiviral Transduction
Explanation #
Use of replication‑deficient lentiviruses to deliver genetic material into dividing and non‑dividing cells, achieving stable integration of transgenes. Example: packaging a CRISPR‑sgRNA library into VSV‑G pseudotyped lentivirus and infecting K562 cells at a multiplicity of infection of 0.3. Practical application: long‑term expression of editing components for pooled screens. Challenges include insertional mutagenesis risk, variability in copy number, and biosafety considerations.
Linear DNA Donor #
Linear DNA Donor
Explanation #
Single‑ or double‑stranded DNA fragments used as repair templates for HDR, often favored for small edits due to higher uptake and reduced random integration. Example: a 200‑nt single‑strand oligodeoxynucleotide containing a silent mutation to prevent re‑cutting after CRISPR editing of the HPRT gene. Practical application: precise point‑mutation introduction without plasmid backbone. Challenges include rapid degradation by nucleases, need for chemical modifications, and limited payload size.
Live‑Cell Imaging of Editing #
Live‑Cell Imaging of Editing
Explanation #
Real‑time visualization of genome‑editing events using fluorescent markers that become active only after successful modification. Example: a split‑GFP system that reconstitutes fluorescence when a CRISPR‑mediated frameshift restores the reading frame. Practical application: monitoring editing kinetics and optimizing delivery conditions. Challenges involve background fluorescence, photobleaching, and ensuring the reporter does not interfere with cellular physiology.
Magnetofection #
Magnetofection
Explanation #
A method that combines nucleic acids with magnetic nanoparticles, using an external magnetic field to concentrate the complexes onto the cell surface and enhance uptake. Example: delivering a plasmid encoding Cas9 into primary hepatocytes using iron‑oxide coated beads and a 0.5 T magnet for 15 minutes. Practical application: gentle transfection of sensitive primary cells. Challenges include nanoparticle toxicity, aggregation, and the need for compatible culture vessels.
Multiplexed Gene Editing #
Multiplexed Gene Editing
Explanation #
Simultaneous targeting of several genomic loci within the same cell, often achieved by co‑delivery of multiple guide RNAs or using Cas nucleases capable of processing polycistronic arrays. Example: knocking out three immune checkpoint genes (PD‑1, CTLA‑4, LAG‑3) in a T‑cell line using a single plasmid encoding three sgRNAs. Practical application: generation of complex disease models and combinatorial therapeutic testing. Challenges include variable editing efficiency across targets, increased off‑target risk, and competition for cellular repair machinery.
Nanopore Sequencing Validation #
Nanopore Sequencing Validation
Explanation #
Use of Oxford Nanopore or similar platforms to sequence edited loci, providing full‑length reads that reveal insertions, deletions, and complex rearrangements. Example: confirming the precise integration of a 2 kb fluorescent reporter into the AAVS1 locus of iPSCs. Practical application: comprehensive validation of genome editing outcomes, especially for large insertions. Challenges include higher error rates compared to short‑read sequencing, need for sufficient coverage, and bioinformatic processing of long reads.
Non‑Homologous End Joining (NHEJ) #
Non‑Homologous End Joining (NHEJ)
Explanation #
The predominant DNA repair pathway that ligates broken DNA ends without a template, often resulting in small insertions or deletions (indels). Example: CRISPR‑Cas9 induced DSB in the KRAS gene repaired by NHEJ leading to a frameshift mutation. Practical application: rapid generation of knockout cell lines. Challenges include unpredictable indel patterns, potential for in‑frame mutations that retain protein function, and competition with HDR.
Off‑Target Analysis #
Off‑Target Analysis
Explanation #
Assessment of unintended cleavage sites by genome‑editing nucleases, using techniques such as GUIDE‑seq, Digenome‑seq, or computational prediction. Example: performing GUIDE‑seq on edited HEK293 cells to identify low‑frequency off‑target sites in the genome. Practical application: ensuring safety of edited cell lines for therapeutic use. Challenges involve detection limits, differentiating true off‑targets from background DNA breaks, and interpreting functional relevance of identified sites.
Plasmid‑Based Transfection #
Plasmid‑Based Transfection
Explanation #
Introduction of circular DNA molecules into cultured cells using chemical reagents or precipitation methods, resulting in transient or stable expression depending on selection. Example: transfecting HEK293 cells with a pCMV‑Cas9‑GFP plasmid using Lipofectamine 3000. Practical application: convenient, low‑cost delivery for pilot experiments. Challenges include variable transfection efficiency across cell types, plasmid backbone integration, and cytotoxicity of reagents.
Prime Editing #
Prime Editing
Explanation #
A versatile editing platform that uses a reverse transcriptase‑fused Cas9 nickase and a prime editing guide RNA (pegRNA) to directly write new genetic information without double‑strand breaks. Example: correcting a pathogenic C>T mutation in the CFTR gene of airway epithelial cells with a single‑step prime edit. Practical application: precise editing of point mutations and small insertions/deletions with reduced indel formation. Challenges include pegRNA design complexity, lower editing efficiency compared to standard CRISPR, and delivery of the large prime editor protein.
Promoter‑Swap Strategy #
Promoter‑Swap Strategy
Explanation #
Replacement of an endogenous promoter with a stronger or inducible promoter to modulate gene expression levels while preserving the coding sequence. Example: swapping the native GAPDH promoter with a CMV promoter at the native locus using HDR. Practical application: creating cell lines with controllable overexpression without ectopic integration. Challenges involve precise targeting, ensuring proper chromatin context, and avoiding disruption of regulatory elements.
RNA‑Guided DNA Base Editing #
RNA‑Guided DNA Base Editing
Explanation #
Subclass of base editors where an adenine (ABE) or cytosine (CBE) deaminase is fused to a Cas9 nickase, enabling conversion of A·T to G·C or C·G to T·A respectively, directed by an sgRNA. Example: using an ABE8e to convert a pathogenic G>A mutation in the HBB gene of erythroid progenitors. Practical application: precise correction of single‑nucleotide diseases without double‑strand breaks. Challenges include off‑target deamination, editing window constraints, and potential RNA off‑target activity.
RNA‑Interference (RNAi) #
RNA‑Interference (RNAi)
Explanation #
A post‑transcriptional gene‑silencing mechanism where double‑stranded RNA molecules trigger degradation of complementary mRNA, reducing protein expression. Example: transfecting siRNA targeting VEGF into endothelial cells to study angiogenesis. Practical application: transient knock‑down for functional assays where permanent genome editing is undesirable. Challenges include transient effect, off‑target silencing, and activation of innate immune responses.
Selectable Marker Cassette #
Selectable Marker Cassette
Explanation #
A genetic element conferring resistance to a specific antibiotic, used to isolate cells that have successfully integrated a transgene. Example: a puromycin‑resistance cassette flanked by loxP sites inserted alongside a fluorescent reporter in a human fibroblast line. Practical application: enrichment of edited clones during selection. Challenges include potential interference with gene expression, need for marker removal in downstream applications, and antibiotic toxicity.
Self‑Cleaving 2A Peptide #
Self‑Cleaving 2A Peptide
Explanation #
A short peptide sequence that causes ribosomal skipping during translation, allowing expression of multiple proteins from a single transcript. Example: linking Cas9, GFP, and a puromycin resistance gene with P2A sequences in a lentiviral construct. Practical application: compact vector design for simultaneous delivery of editing components and selectable markers. Challenges include incomplete cleavage leading to fusion proteins and variability in expression levels of downstream genes.
Single‑Cell Cloning #
Single‑Cell Cloning
Explanation #
Isolation of individual cells to derive clonal populations, essential for confirming homogeneous editing outcomes. Example: performing limiting‑dilution cloning of edited HeLa cells to obtain single‑cell derived colonies. Practical application: generation of isogenic cell lines for comparative studies. Challenges include low cloning efficiency, potential selection bias toward fast‑growing clones, and the need for extensive screening to identify desired edits.
Single‑Strand Oligodeoxynucleotide (ssODN) Donor #
Single‑Strand Oligodeoxynucleotide (ssODN) Donor
Explanation #
Short, chemically synthesized DNA fragments used as donors for HDR, typically 100‑200 nucleotides long, containing the desired edit flanked by homology arms. Example: a 120‑nt ssODN introducing a silent mutation to disrupt a PAM site after CRISPR editing of the TP53 gene. Practical application: precise base changes without plasmid backbone. Challenges include rapid degradation, need for phosphorothioate modifications, and limited capacity for large insertions.
SNP‑Based Editing #
SNP‑Based Editing
Explanation #
Targeted modification of a single nucleotide at a known polymorphic site, often using base editors or prime editors to correct disease‑associated variants. Example: converting a pathogenic G>C SNP in the LDLR gene of hepatocyte cultures using a cytosine base editor. Practical application: creation of patient‑specific disease models and potential therapeutic correction. Challenges involve achieving high editing purity, avoiding by‑stander edits, and confirming functional rescue.
Spheroid Culture Transfection #
Spheroid Culture Transfection
Explanation #
Delivery of genetic material into three‑dimensional cell aggregates, which presents barriers to reagent diffusion and requires specialized protocols. Example: using a low‑voltage electroporation protocol to introduce CRISPR plasmids into tumor spheroids. Practical application: editing of cells within physiologically relevant 3D models. Challenges include heterogeneous transfection efficiency, limited reagent access to inner cells, and maintaining spheroid integrity.
Stable Cell Line Generation #
Stable Cell Line Generation
Explanation #
Creation of cell populations that permanently retain introduced genetic elements, typically through viral integration or selection of antibiotic‑resistant clones. Example: generating a CHO cell line stably expressing a secreted IgG antibody after lentiviral transduction and puromycin selection. Practical application: production of biologics and long‑term functional studies. Challenges involve insertional mutagenesis, variable expression levels, and potential silencing over time.
Targeted Locus Amplification (TLA) #
Targeted Locus Amplification (TLA)
Explanation #
A method that uses proximity ligation to amplify and sequence DNA surrounding a known integration site, allowing precise mapping of transgene insertion. Example: applying TLA to verify the exact location of a CRISPR donor cassette in a mouse embryonic stem cell line. Practical application: confirming safe‑harbor integration and detecting rearrangements. Challenges include requirement for high‑quality DNA, complex library preparation, and interpretation of repetitive regions.
Transfection Reagent Toxicity #
Transfection Reagent Toxicity
Explanation #
Cytotoxic effects caused by chemical transfection agents, which can reduce cell viability and alter cellular physiology. Example: observing a 30 % drop in viability in primary T cells after Lipofectamine 2000 transfection at the recommended dose. Practical application: necessity to titrate reagent amounts for each cell type to balance efficiency and health. Challenges include batch‑to‑batch variability, serum interference, and difficulty in scaling to large volumes.
Transposon‑Mediated Insertion #
Transposon‑Mediated Insertion
Explanation #
Use of DNA transposases to catalyze cut‑and‑paste insertion of a transgene into the host genome, offering a non‑viral alternative for stable integration. Example: delivering a PiggyBac transposon carrying a fluorescent reporter into human iPSCs using a co‑transfected transposase expression plasmid. Practical application: rapid generation of stable lines with minimal footprint. Challenges include random integration sites, potential remobilization, and need for careful screening for safe insertion.
Truncated sgRNA (tru‑sgRNA) #
Truncated sgRNA (tru‑sgRNA)
Explanation #
Shortened guide RNAs (typically 17‑18 nucleotides) that maintain on‑target activity while reducing off‑target cleavage by Cas9. Example: using a 17‑nt tru‑sgRNA to edit the CDKN2A locus with decreased off‑target sites compared to a full‑length 20‑nt guide. Practical application: improving safety of genome editing in therapeutic contexts. Challenges involve variable activity across targets and the need for empirical validation.
Turbo‑GFP Reporter System #
Turbo‑GFP Reporter System
Explanation #
A fast‑maturing variant of GFP used as a visual marker for successful genome editing, often inserted at the target locus via HDR. Example: knocking in Turbo‑GFP into the COL1A1 gene of fibroblasts to monitor collagen expression in real time. Practical application: immediate visual confirmation of editing and tracking of gene expression dynamics. Challenges include potential interference with protein function and phototoxicity during imaging.
Viral‑Free CRISPR Delivery #
Viral‑Free CRISPR Delivery
Explanation #
Non‑viral strategies to introduce CRISPR components, such as delivering Cas9‑sgRNA ribonucleoprotein complexes directly into cells. Example: using a lipid‑nanoparticle formulation to deliver Cas9 RNPs into primary human T cells. Practical application: reduced risk of insertional mutagenesis and transient presence of editing machinery. Challenges include achieving high delivery efficiency, maintaining RNP stability, and scaling up for large‑volume applications.
Viral Vector Pseudotyping #
Viral Vector Pseudotyping
Explanation #
Replacement of the native viral envelope protein with an alternative (e.g., VSV‑G) to broaden the range of cells that can be transduced. Example: pseudotyping a lentiviral vector with VSV‑G to enable efficient transduction of both dividing and non‑dividing neuronal cultures. Practical application: expanding the applicability of viral delivery across diverse cell types. Challenges involve potential cytotoxicity of the envelope protein, altered immune recognition, and requirement for high‑titer production.
Viral Integration Site Analysis #
Viral Integration Site Analysis
Explanation #
Determination of where a viral vector has inserted its genome within the host DNA, often using ligation‑mediated PCR followed by sequencing. Example: mapping lentiviral integration sites in a CAR‑T cell product to assess clonal diversity and safety. Practical application: ensuring that integration has not disrupted oncogenes or tumor suppressors. Challenges include bias toward certain genomic regions, difficulty amplifying junctions in repetitive DNA, and interpreting the functional impact of insertions.
Virus‑Like Particle (VLP) Delivery #
Virus‑Like Particle (VLP) Delivery
Explanation #
Engineered particles that mimic viral capsids but lack viral genomes, used to package and deliver CRISPR ribonucleoproteins to cells. Example: using HIV‑derived VLPs to transport Cas9‑sgRNA complexes into human hematopoietic stem cells. Practical application: high‑efficiency, low‑immunogenic delivery without integration risk. Challenges include production complexity, capsid stability, and potential immune clearance.
Whole‑Genome Sequencing (WGS) Validation #
Whole‑Genome Sequencing (WGS) Validation
Explanation #
Comprehensive sequencing of the entire genome of edited cells to detect off‑target mutations, large structural variations, and unintended insertions. Example: performing 30× WGS on a CRISPR‑edited iPSC line to confirm absence of off‑target indels. Practical application: regulatory compliance for clinical‑grade cell therapies. Challenges include high cost, massive data analysis, and distinguishing true edits from sequencing artifacts.
Yeast‑Based Assembly (Golden Gate) #
Yeast‑Based Assembly (Golden Gate)
Explanation #
A cloning strategy that uses type IIS restriction enzymes to assemble multiple DNA fragments in a predefined order in a single reaction, facilitating rapid construction of complex vectors. Example: assembling a multi‑sgRNA cassette with promoters, terminators, and Cas12a coding sequence using Golden Gate. Practical application: streamlined generation of multiplexed editing constructs. Challenges include ensuring absence of internal restriction sites, reaction efficiency, and verification of correct assembly.